Medical devices are an essential part of modern healthcare, ranging from relatively simple products used during routine examinations to sophisticated implantable devices, diagnostic technologies, robotic systems and artificial intelligence-enabled medical technologies.
But what exactly qualifies as a medical device?
In the United States, the answer is particularly important because whether a product meets the definition of a medical device—and how that device is classified—can determine the regulatory requirements a manufacturer must satisfy before and after bringing the product to market.
The U.S. Food and Drug Administration (FDA) regulates medical devices using a risk-based framework. Devices are generally placed into one of three regulatory classes—Class I, Class II or Class III—with regulatory requirements increasing according to the controls necessary to provide reasonable assurance of safety and effectiveness.
Understanding these classifications is fundamental for medical device manufacturers, healthcare professionals, investors and others following the rapidly evolving MedTech industry.
Under Section 201(h)(1) of the Federal Food, Drug, and Cosmetic Act, the definition of a device encompasses an instrument, apparatus, implement, machine, implant, in vitro reagent or other similar or related article, including certain components and accessories.
Among other criteria, a product may meet the definition when it is intended for use in diagnosing disease or other conditions; curing, mitigating, treating or preventing disease; or affecting the structure or function of the human or animal body.
A critical distinction between many medical devices and drugs is how they achieve their primary intended purpose. Under the statutory definition, a device does not achieve its primary intended purposes through chemical action within or on the body and is not dependent upon being metabolized to achieve those primary intended purposes.
In practical terms, the medical device category is extraordinarily broad.
Medical devices may include products used for:
Diagnosis and patient monitoring
Disease prevention and treatment
Surgery and minimally invasive procedures
Medical imaging
Cardiovascular intervention
Orthopedic procedures
Laboratory and in vitro diagnostic testing
Patient monitoring
Implantation
Rehabilitation
Digital health applications
Software-based medical functions
Artificial intelligence-enabled healthcare technologies
Whether a particular product legally qualifies as a medical device depends on factors that include its intended use and how the product meets the statutory definition.
The FDA uses a risk-based medical device classification system.
Medical devices are assigned to one of three regulatory classes:
Class I — General Controls
Class II — General Controls and Special Controls
Class III — General Controls and Premarket Approval
In general, Class I encompasses the lowest-risk devices, while Class III includes devices presenting the highest level of risk.
The classification is important because it helps determine the regulatory controls and, where applicable, the type of premarket submission required before a device can legally enter the U.S. market.
The FDA has established classifications for approximately 1,700 generic types of medical devices and organizes them into medical specialty panels.
Class I medical devices generally present the lowest level of risk.
These devices are subject to FDA General Controls. Depending on the particular device and applicable regulations, a Class I device may be exempt from premarket notification requirements.
General Controls form the foundation of FDA medical device regulation and can include requirements involving:
Establishment registration and device listing
Labeling
Records and reports
Restrictions against adulterated or misbranded devices
Applicable manufacturing requirements
Medical device reporting and other postmarket obligations
Importantly, describing a device as “Class I” does not mean that FDA requirements can simply be ignored.
Manufacturers must determine the specific classification regulation, product code, exemptions and other requirements applicable to their particular device.
Class II medical devices generally present greater risk than Class I devices and typically require additional regulatory controls.
Class II devices are subject to General Controls and, when applicable, Special Controls.
Special Controls may include device-specific requirements such as:
Performance standards
Special labeling requirements
Testing requirements
Patient registries
Postmarket surveillance
Guidance recommendations
Other measures designed to address identified risks
Many Class II medical devices require an FDA 510(k) premarket notification before they can be marketed in the United States, although exemptions exist for certain device types.
The 510(k) pathway is one of the best-known medical device regulatory pathways in the United States.
For devices requiring a 510(k), a manufacturer submits a premarket notification to the FDA demonstrating that the new device is substantially equivalent to an appropriate legally marketed predicate device.
This is an important terminology distinction:
A device that successfully completes the 510(k) process is generally described as FDA cleared, rather than FDA approved.
That distinction matters when manufacturers, healthcare organizations and news publications describe a device’s regulatory status.
Class III medical devices represent the highest-risk regulatory category.
These devices may include products that support or sustain human life, are implanted, or present a potential unreasonable risk of illness or injury.
For Class III devices requiring Premarket Approval, manufacturers generally must submit a PMA application.
Premarket Approval is FDA’s most rigorous type of medical device marketing submission. The PMA review standard relies on an independent demonstration of reasonable assurance of the device’s safety and effectiveness for its intended use.
Because of the potential risks associated with Class III technologies, manufacturers may need to provide extensive scientific evidence supporting their applications.
The terms FDA cleared and FDA approved are frequently used interchangeably in everyday conversation, but they have different regulatory meanings.
FDA clearance is commonly associated with the 510(k) pathway.
In a 510(k), FDA evaluates whether the new device is substantially equivalent to an appropriate legally marketed predicate device.
FDA approval, in the medical device context, is commonly associated with a successful Premarket Approval application for a Class III device.
A PMA involves FDA’s scientific and regulatory review of evidence supporting the safety and effectiveness of the device.
For this reason, accurate reporting should distinguish between an FDA-cleared medical device and an FDA-approved medical device.
Not every innovative medical device has an existing legally marketed predicate.
The FDA’s De Novo classification process provides a regulatory pathway for certain novel medical devices for which there is no legally marketed predicate but for which General Controls alone, or General and Special Controls, can provide reasonable assurance of safety and effectiveness.
A successful De Novo request results in the creation of a new Class I or Class II device classification.
Once classified, that device type may potentially serve as a predicate for future 510(k) submissions when appropriate.
The De Novo pathway has therefore become particularly important for novel medical technologies that do not fit neatly into an established device category.
Manufacturers should not determine classification merely by looking at whether another device appears physically similar to their product.
The FDA explains that device classification depends on factors including a product’s intended use and indications for use.
A manufacturer can research FDA’s Product Classification Database and the applicable classification regulations in Title 21 of the Code of Federal Regulations.
FDA has organized classified devices into medical specialty areas covering fields such as:
Cardiovascular
Dental
Ear, Nose and Throat
Gastroenterology and Urology
General and Plastic Surgery
General Hospital
Neurology
Obstetrical and Gynecological
Ophthalmic
Orthopedic
Physical Medicine
Radiology
The appropriate regulation and product code can help determine the device’s class and applicable marketing requirements.
No.
Not every medical device requires a 510(k), De Novo request or PMA before entering the U.S. market.
Certain Class I and Class II devices may be exempt from 510(k) requirements, subject to applicable limitations on those exemptions.
However, being exempt from premarket notification does not necessarily mean that a manufacturer is exempt from all FDA requirements.
Depending on the device, other requirements may continue to apply, including establishment registration, device listing, labeling, applicable manufacturing requirements and postmarket obligations.
General Controls are the baseline regulatory authorities that apply to medical devices across the three classes unless an applicable exemption exists.
They address areas including:
Adulteration
Misbranding
Establishment registration
Device listing
Premarket notification requirements where applicable
Records and reports
Restricted devices
Applicable manufacturing requirements
Other regulatory responsibilities
The objective is to provide a regulatory foundation for helping assure medical device safety and effectiveness throughout the product lifecycle.
FDA regulation does not necessarily end when a medical device receives clearance or approval.
Manufacturers may remain subject to postmarket regulatory responsibilities involving areas such as adverse-event reporting, corrections and removals, device tracking where applicable, quality requirements and postmarket surveillance.
This lifecycle approach is particularly important because some device-related risks may become apparent only after a technology is used more broadly in real-world clinical practice.
Medical device classification has implications far beyond a regulatory label.
A device’s classification can influence:
Product development strategy
Testing requirements
Clinical evidence
Regulatory timelines
Premarket submissions
Manufacturing and quality requirements
Labeling
Postmarket obligations
Commercialization strategy
Investment and acquisition decisions
For emerging medical technology companies, understanding the likely regulatory pathway early in development can be an important part of product planning.
For healthcare professionals and investors, understanding whether a product is FDA cleared, FDA approved, De Novo classified or exempt from premarket notification provides valuable context when evaluating new medical technologies.
The definition of a medical device encompasses an increasingly diverse range of technologies.
Traditional surgical instruments and implants now exist alongside sophisticated diagnostic platforms, connected monitoring technologies, software-driven systems, robotic technologies and artificial intelligence-enabled medical devices.
Regardless of technological complexity, the underlying regulatory principle remains risk-based: the FDA determines the regulatory controls necessary to provide reasonable assurance of a device’s safety and effectiveness.
For manufacturers, healthcare professionals, investors and other MedTech stakeholders, understanding the distinction between Class I, Class II and Class III devices—and between regulatory pathways such as 510(k), De Novo and PMA—is essential to understanding how medical technologies reach the U.S. market.
What is considered a medical device?
A medical device can include an instrument, machine, implant, in vitro reagent, software function or other qualifying product intended for purposes such as diagnosing, preventing, treating or mitigating disease, or affecting the body’s structure or function, provided it meets the applicable statutory definition.
What are the three FDA medical device classes?
The three regulatory classes are Class I, Class II and Class III. Class I generally represents the lowest-risk category, while Class III represents the highest-risk category and is subject to the most stringent regulatory controls.
Do all medical devices need FDA approval?
No. Different medical devices follow different regulatory pathways. Some devices are exempt from premarket notification, many enter the market through 510(k) clearance, novel low- to moderate-risk devices without a predicate may use the De Novo pathway, and certain high-risk Class III devices require Premarket Approval.
Is FDA clearance the same as FDA approval?
No. FDA clearance generally refers to a device that has successfully completed the 510(k) process, while FDA approval is commonly associated with successful review of a Premarket Approval application.
What does 510(k) mean for a medical device?
A 510(k) is a premarket notification in which a manufacturer demonstrates that a device is substantially equivalent to an appropriate legally marketed predicate device.
What is a Class III medical device?
Class III is the highest-risk medical device classification. These devices may include technologies that sustain or support life, are implanted or present a potential unreasonable risk of illness or injury. Class III devices requiring PMA must receive FDA approval before marketing.
Editor’s Note: This article on what is a medical device is intended for general informational and educational purposes and should not be considered legal, regulatory or medical advice. Medical device manufacturers should consult applicable FDA regulations and current FDA guidance when determining requirements for a specific product. View current news.